Search Results - "P S Yeong, Joe"

Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers by Sundar, Raghav, Smyth, Elizabeth C., Peng, Siyu, Yeong, Joe P. S., Tan, Patrick

“…Immune checkpoint inhibition has transformed cancer treatment. For gastroesophageal cancer, this class of drugs have demonstrated durable responses and…”
Get full text

Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer by Hoppe, Michal M, Jaynes, Patrick, Wardyn, Joanna D, Upadhyayula, Sai Srinivas, Tan, Tuan Zea, Lie, Stefanus, Lim, Diana G Z, Pang, Brendan N K, Lim, Sherlly, P S Yeong, Joe, Karnezis, Anthony, Chiu, Derek S, Leung, Samuel, Huntsman, David G, Sedukhina, Anna S, Sato, Ko, Topp, Monique D, Scott, Clare L, Choi, Hyungwon, Patel, Naina R, Brown, Robert, Kaye, Stan B, Pitt, Jason J, Tan, David S P, Jeyasekharan, Anand D

“…Early relapse after platinum chemotherapy in epithelial ovarian cancer (EOC) portends poor survival. A‐priori identification of platinum resistance is…”
Get full text

Higher densities of tumour‐infiltrating lymphocytes and CD4+ T cells predict recurrence and progression of ductal carcinoma in situ of the breast by Thike, Aye Aye, Chen, Xiaoyang, Koh, Valerie Cui Yun, Binte Md Nasir, Nur Diyana, Yeong, Joe P S, Bay, Boon Huat, Tan, Puay Hoon

“…Aims Host immunity influences cancer progression and therapeutic response. We investigated the potential of tumour‐infiltrating lymphocytes (TILs) around…”
Get full text

Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence by Tien, Tracy Z, Lee, Justina N L W, Lim, Jeffrey C T, Chen, Xiao‐Yang, Thike, Aye Aye, Tan, Puay Hoon, Yeong, Joe P S

“…Breast cancer is the most common malignancy and the leading cause of cancer death in females worldwide. Treatment is challenging, especially for those who are…”
Get full text

Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities by Chua, Khi Pin, Teng, Yvonne H F, Tan, Aaron C, Takano, Angela, Alvarez, Jacob J S, Nahar, Rahul, Rohatgi, Neha, Lai, Gillianne G Y, Aung, Zaw Win, Yeong, Joe P S, Lim, Kiat Hon, Naeini, Marjan Mojtabavi, Kassam, Irfahan, Jain, Amit, Tan, Wan Ling, Gogna, Apoorva, Too, Chow Wei, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Anantham, Devanand, Phua, Ghee Chee, Tan, Bien Soo, Lee, Yin Yeng, Wang, Lanying, Teo, Audrey S M, Khng, Alexis Jiaying, Lim, Ming Jie, Suteja, Lisda, Toh, Chee Keong, Lim, Wan-Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Hillmer, Axel M, Skanderup, Anders J, Tan, Daniel S W

“…Despite the established role of EGFR tyrosine kinase inhibitors (TKIs) in -mutated NSCLC, drug resistance inevitably ensues, with a paucity of treatment…”
Get full text

Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non-Small-Cell Lung Cancer by Tan, Aaron C, Saw, Stephanie P L, Chen, Jianbin, Lai, Gillianne G Y, Oo, Hlaing Nwe, Takano, Angela, Lau, Dawn P X, Yeong, Joe P S, Tan, Gek San, Lim, Kiat Hon, Skanderup, Anders J, Chan, Johan W K, Teh, Yi Lin, Rajasekaran, Tanujaa, Jain, Amit, Tan, Wan Ling, Ng, Quan Sing, Kanesvaran, Ravindran, Lim, Wan-Teck, Ang, Mei-Kim, Tan, Daniel S W

“…-altered non-small-cell lung cancer (NSCLC) represents a diverse subgroup, including mutations, amplifications, and overexpression. However, exon 20 insertion…”
Get more information

Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences by Chua, Melvin L. K., Hakansson, Alexander K., Ong, Enya H. W., Hong, Boon Hao, Miao, Jing Jing, Sim, Adelene Y. L., Tan, Janice S. H., Tan, Kah Min, Lee, Gabrielle C. J., Low, Kar Perng, Tuan, Jeffrey K. L., Tan, Terence W. K., Wang, Michael L. C., Yeong, Joe P. S., Tan, Michael C. S., Lee, Lui Shiong, Kanesvaran, Ravindran, Zhao, Xin, Ho, Julian, Spratt, Daniel E., Schaeffer, Edward M., Tay, Kae‐Jack, Liu, Yang, Davicioni, Elai, Khor, Li Yan

“…Abbreviations AR Androgen receptor CPGEA Chinese Prostate Cancer Genome and Epigenome Atlas CHD1 Chromodomain-Helicase DNA-binding 1 DMFS Distant…”
Get full text

A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC by Lai, Gillianne G.Y., Yeo, Jia Chi, Jain, Amit, Zhou, Siqin, Pang, Mengyuan, Alvarez, Jacob J.S., Sim, Ngak Leng, Tan, Aaron C., Suteja, Lisda, Lim, Tze Wei, Guo, Yu Amanda, Shen, Meixin, Saw, Stephanie P.L., Rohatgi, Neha, Yeong, Joe P.S., Takano, Angela, Lim, Kiat Hon, Gogna, Apoorva, Too, Chow Wei, Da Zhuang, Kun, Tan, Wan Ling, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Wang, Lanying, Toh, Chee Keong, Lim, Wan-Teck, Tam, Wai Leong, Tan, Sze Huey, Skanderup, Anders M.J., Tan, Eng-Huat, Tan, Daniel S.W.

“…Although immune checkpoint inhibitors (ICIs) have dramatically improved outcomes for nononcogene-addicted NSCLC, monotherapy with programmed cell death…”
Get full text